CTLA4 and neoplasm: However, for some tumors, such as melanoma, the treatment response rate was less than half, suggesting that the immune escape of tumor cells depends not only on immune checkpoints, such as CTLA-4 and PD-1/PD-L1 but also other immunosuppressive modalities [14,15].